Visiomed Group SA
EPA:ALVMG.PA
0.1726 (EUR) • At close July 2, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 13.706 | 14.445 | 7.173 | 18.976 | 10.237 | 8.738 | 10.458 | 9.491 | 10.891 | 13.307 | 11.268 | 13.732 | 12.548 | 10.288 | 4.384 |
| Cost of Revenue
| 7.408 | 11.244 | 7.888 | 22.736 | 18.132 | 16.199 | 16.223 | 16.287 | 13.416 | 10.752 | 9.018 | 10.8 | 8.877 | 7.522 | 3.331 |
| Gross Profit
| 6.298 | 3.201 | -0.715 | -3.76 | -7.895 | -7.461 | -5.765 | -6.796 | -2.525 | 2.555 | 2.25 | 2.932 | 3.672 | 2.766 | 1.053 |
| Gross Profit Ratio
| 0.46 | 0.222 | -0.1 | -0.198 | -0.771 | -0.854 | -0.551 | -0.716 | -0.232 | 0.192 | 0.2 | 0.213 | 0.293 | 0.269 | 0.24 |
| Reseach & Development Expenses
| 0 | 0.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 0.165 | 1.216 | 0.129 | 0.45 | 0.473 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Expenses
| -0.023 | -0.039 | -0.424 | -1.154 | -3.845 | 0 | 0 | 0 | 0 | -0.014 | -0.205 | 0 | 0 | 0 | -0.178 |
| Operating Expenses
| 5.346 | 7.115 | 2.962 | 2.841 | 13.954 | 10.933 | 7.33 | 6.833 | 5.478 | 4.869 | 4.162 | 5.293 | 5.474 | 4.307 | 2.052 |
| Operating Income
| 0.787 | -4.368 | -3.677 | -6.581 | -21.85 | -1.938 | -13.095 | -13.63 | -8.003 | -2.314 | -1.912 | -2.362 | -1.802 | -1.541 | -1 |
| Operating Income Ratio
| 0.057 | -0.302 | -0.513 | -0.347 | -2.134 | -0.222 | -1.252 | -1.436 | -0.735 | -0.174 | -0.17 | -0.172 | -0.144 | -0.15 | -0.228 |
| Total Other Income Expenses Net
| 0.151 | 0.079 | -0.551 | 1.336 | -1.954 | -1.919 | -0.403 | -0.191 | 0.649 | 0.002 | -0.092 | -0.17 | -0.166 | -0.097 | -0.225 |
| Income Before Tax
| 1.52 | -5.132 | -4.228 | -5.245 | -24.018 | -20.001 | -13.498 | -13.821 | -7.353 | -2.312 | -2.305 | -2.532 | -1.968 | -1.638 | -1.226 |
| Income Before Tax Ratio
| 0.111 | -0.355 | -0.589 | -0.276 | -2.346 | -2.289 | -1.291 | -1.456 | -0.675 | -0.174 | -0.205 | -0.184 | -0.157 | -0.159 | -0.28 |
| Income Tax Expense
| -0.037 | 0.113 | 0.142 | -0.164 | 0.133 | 0.345 | 0.508 | 0.444 | -0.071 | -0.015 | 0.002 | -0.001 | -0.002 | -0.001 | -0.004 |
| Net Income
| 0.902 | -5.277 | -4.457 | -5.15 | -24.053 | -19.787 | -13.154 | -13.412 | -7.282 | -2.598 | -2.608 | -2.806 | -2.303 | -2.068 | -1.222 |
| Net Income Ratio
| 0.066 | -0.365 | -0.621 | -0.271 | -2.35 | -2.264 | -1.258 | -1.413 | -0.669 | -0.195 | -0.231 | -0.204 | -0.184 | -0.201 | -0.279 |
| EPS
| 0.003 | -0.02 | -0.071 | -0.2 | -1.68 | -11.18 | -16.72 | -26.99 | -17.91 | -13.61 | -17.19 | -25.79 | -26.27 | -16.96 | -10.03 |
| EPS Diluted
| 0.003 | -0.02 | -0.071 | -0.2 | -1.68 | -11.18 | -16.72 | -26.99 | -17.91 | -13.61 | -17.19 | -25.79 | -26.27 | -16.96 | -10.03 |
| EBITDA
| 4.191 | -1.17 | -2.864 | -6.696 | -18.211 | -17.586 | -12.653 | -12.513 | -7.928 | -1.464 | -1.165 | -1.719 | -1.189 | -1.019 | -0.879 |
| EBITDA Ratio
| 0.306 | -0.081 | -0.399 | -0.353 | -1.779 | -2.013 | -1.21 | -1.318 | -0.728 | -0.11 | -0.103 | -0.125 | -0.095 | -0.099 | -0.201 |